Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Wiener Neustadt
Clinical trial register · Austria

Clinical Trials in Wiener Neustadt, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Austria and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1587 matching records held by the registry are in this view. Synced 18 Nov 2026, 03:18 UTC
1587
Studies in scope
all four open statuses
858
Recruiting now
open to new participants
343
Lead sponsors
across recruiting studies
Top sites
Vienna 1012 Graz 513 Linz 436 Innsbruck 397 Salzburg 292

Trials with a site in Wiener Neustadt

33 of 1587 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Austria
Start
Recruiting
Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Sacrocolpopexy (ProGYNious)
NCT07497321Pelvic Organ Prolapse (POP), Synthetic Mesh, Laparoscopic Surgery, Gynecologic Laparoscopic Surgery
A.M.I. Agency for Medical Innovations GmbH
Not applicable
100
Wiener Neustadt
2026-10-28
Recruiting
ABCSG R07 Rectal Cancer Registry
NCT07780305Rectal Cancer, Adenocarcinoma of Rectum
Austrian Breast & Colorectal Cancer Study Group
Observational
600
Wiener Neustadt, Salzburg, Graz, Innsbruck, Linz
2026-09-16
Recruiting
AstraZeneca
Phase 3
2,800
Feldkirch, Innsbruck, Linz, Sankt Pölten, Vienna, Wels, Wiener Neustadt
2026-09-01
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Graz, Innsbruck, Linz, Salzburg, Vienna, Wels, Wiener Neustadt
2026-04-21
Recruiting
AstraZeneca
Phase 3
2,130
Linz, Rankweil, Vienna, Wiener Neustadt
2026-02-03
Recruiting
Safety and Performance of a Pelvic Floor Mesh Implant (LatGYNious)
NCT07066761Pelvic Organ Prolapse (POP), Genital Prolapse, Uterus Prolapse, Laparoscopic Surgery
A.M.I. Agency for Medical Innovations GmbH
Not applicable
85
Sankt Johann in Tirol, Wiener Neustadt
2025-11-01
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
140
Linz, Salzburg, Wiener Neustadt
2025-10-27
Recruiting
Eli Lilly and Company
Phase 3
4,500
Graz, Salzburg, Vienna, Wiener Neustadt
2025-10-15
Recruiting
AstraZeneca
Phase 3
840
Linz, Salzburg, Vienna, Wiener Neustadt
2025-03-01
Recruiting
Daiichi Sankyo
Phase 3
726
Graz, Innsbruck, Vienna, Wiener Neustadt
2025-02-27
Recruiting
Novartis Pharmaceuticals
Observational
3,250
Wiener Neustadt, Innsbruck, Linz, Graz, Klagenfurt, Leoben, Schwaz, Steyr
2025-02-20
Recruiting
Fast Discharge After Acute Myocardial Infarction Discharge MI
NCT06744322Acute Myocardial Infarction (AMI)
Medical University Innsbruck
Not applicable
2,070
Wiener Neustadt, Schwarzach im Pongau, Salzburg, Graz, Innsbruck, Wels, Feldkirch
2024-12-01
Recruiting
AstraZeneca
Phase 3
620
Graz, Linz, Salzburg, Vienna, Wiener Neustadt
2024-08-12
Recruiting
Italfarmaco
Phase 3
220
Wiener Neustadt, Vienna, Linz, Wels
2024-03-26
Recruiting
Austrian Hypertrophic Cardiomyopathy Registry
NCT06368518Hypertrophic Cardiomyopathy
Medical University of Graz
Observational
1,000
Linz, Sankt Pölten, Wiener Neustadt, Salzburg, Schwarzach im Pongau, Vienna, Graz, Innsbruck
2024-03-08
Active, closed
TransThera Sciences (Nanjing), Inc.
Phase 3
200
Linz, Wiener Neustadt
2023-12-20
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
257
Linz, Vienna, Wels, Wiener Neustadt, Zams
2023-12-05
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
Olema Oncology, Inc.
Phase 3
510
Wels, Wiener Neustadt
2023-11-16
Recruiting
EBG MedAustron GmbH
Not applicable
30
Wiener Neustadt
2022-05-16
Active, closed
Mirati Therapeutics Inc.
Phase 3
461
Innsbruck, Vienna, Wiener Neustadt
2021-06-24
Active, closed
Merck Sharp & Dohme LLC
Phase 3
342
Wiener Neustadt, Vienna, Graz, Innsbruck, Salzburg
2021-06-18
Recruiting
Biosense Webster, Inc.
Observational
8,000
Graz, Linz, Wiener Neustadt
2021-02-22
Active, closed
University of Kiel
Observational
2,300
Wiener Neustadt
2021-02-22
Recruiting
SCAD : a Registry of Spontaneous Coronary Artery Dissection
NCT06601270Spontaneous Coronary Artery Dissection
European Society of Cardiology
Observational
1,500
Innsbruck, Vienna, Wiener Neustadt
2021-01-30
Recruiting
EBG MedAustron GmbH
Not applicable
10
Wiener Neustadt
2020-09-14
Recruiting
Pierre Fabre Pharma GmbH
Observational
750
Graz, Innsbruck, Klagenfurt, Linz, Salzburg, Vienna, Wiener Neustadt
2019-10-17
Active, closed
Exelixis
Phase 3
855
Wiener Neustadt, Linz, Salzburg, Vienna
2019-06-25
Recruiting
Italian Sarcoma Group
Not applicable
100
Graz, Wiener Neustadt
2017-03-16
Recruiting
Ion Therapy Patient Registry
NCT03049072Ion Beam Radiation Therapy for Tumor Patients
EBG MedAustron GmbH
Observational
2,800
Wiener Neustadt
2016-12
Active, closed
Eli Lilly and Company
Phase 2
309
Wiener Neustadt, Salzburg, Vienna
2016-05-19
Rows per page Showing 1–33 of 33
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Austrian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 November 2026. https://priyalifescience.com/clinical-trials-austria/city/wiener-neustadt

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Austria and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,587 studies in total at the last sync on 18 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 33 of those studies with a site in Wiener Neustadt.

How many clinical trials are recruiting in Wiener Neustadt?

23 of the 33 studies on this page are recruiting new participants as of the 18 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wiener Neustadt), 33 studies
PhaseStudiesRecruitingShare
Phase 316948.5%
Observational9727.3%
Not applicable6618.2%
Phase 2216.1%

Most active sponsors

Lead sponsors with the most studies (Wiener Neustadt)
Lead sponsorStudiesRecruiting
AstraZeneca54
EBG MedAustron GmbH33
A.M.I. Agency for Medical Innovations GmbH22
Eli Lilly and Company21
Amgen11
Austrian Breast & Colorectal Cancer Study Group11
Biosense Webster, Inc.11
Bristol-Myers Squibb10
Daiichi Sankyo11
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.